Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06JPP
|
|||
Former ID |
DNC003999
|
|||
Drug Name |
LG-121071
|
|||
Synonyms |
LGD-121071
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H15F3N2O
|
|||
Canonical SMILES |
CCC1CCNC2=C1C=C3C(=CC(=O)NC3=C2)C(F)(F)F
|
|||
InChI |
1S/C15H15F3N2O/c1-2-8-3-4-19-12-7-13-10(5-9(8)12)11(15(16,17)18)6-14(21)20-13/h5-8,19H,2-4H2,1H3,(H,20,21)
|
|||
InChIKey |
SZPPQFARTYXRKU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Androgen receptor messenger RNA (AR mRNA) | Target Info | Inhibitor | [1] |
KEGG Pathway | Oocyte meiosis | |||
Pathways in cancer | ||||
Prostate cancer | ||||
NetPath Pathway | EGFR1 Signaling Pathway | |||
AndrogenReceptor Signaling Pathway | ||||
FSH Signaling Pathway | ||||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | |||
Coregulation of Androgen receptor activity | ||||
Regulation of Androgen receptor activity | ||||
Nongenotropic Androgen signaling | ||||
Regulation of nuclear beta catenin signaling and target gene transcription | ||||
FOXA1 transcription factor network | ||||
Notch-mediated HES/HEY network | ||||
Reactome | Nuclear Receptor transcription pathway | |||
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Integrated Pancreatic Cancer Pathway | ||||
Prostate Cancer | ||||
Integrated Breast Cancer Pathway | ||||
Nuclear Receptors | ||||
Androgen receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. J Med Chem. 2007 May 17;50(10):2486-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.